Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer

The five-year survival rate for ovarian cancer patients remains below 50%, underscoring the need for innovative therapies. One promising approach involves engineering T cells to specifically target proteins uniquely overexpressed in tumors, thereby controlling tumor growth without toxicity to health...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Proceedings of the National Academy of Sciences - PNAS Jg. 122; H. 39; S. e2419888122
Hauptverfasser:	Alencar, Gabriel F, Mohamed, Asmaa O, Burnett, Madison G, Jean, Samantha St, Nelson, Anders R, Su, Yapeng, Voillet, Valentin, Bates, Breanna M, Rodgers Suarez, Magdalia, Ruskin, Susan L, Trieu, Lam, Lam, Jennifer L, Bekiranov, Stefan, Gottardo, Raphael, Greenberg, Philip D, Anderson, Kristin G
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 30.09.2025
Schlagworte:	Animals Antigens, CD - genetics Antigens, CD - immunology Antigens, CD - metabolism Cell Line, Tumor Disease Models, Animal Female Hepatitis A Virus Cellular Receptor 2 - antagonists & inhibitors Hepatitis A Virus Cellular Receptor 2 - immunology Hepatitis A Virus Cellular Receptor 2 - metabolism Humans Immune Checkpoint Inhibitors - pharmacology Immunotherapy, Adoptive - methods Lymphocyte Activation Gene 3 Protein Mesothelin Mice Ovarian Neoplasms - genetics Ovarian Neoplasms - immunology Ovarian Neoplasms - pathology Ovarian Neoplasms - therapy Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology T-Lymphocytes - immunology Tumor Microenvironment - immunology checkpoint blockade T cell engineering ovarian cancer adoptive cell therapy immunotherapy
ISSN:	1091-6490, 1091-6490
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!